These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32664137)

  • 1. Chronic inflammatory demyelinating polyradiculoneuropathy relapse after mexiletine withdrawal in a patient with concomitant myotonia congenita: A case report on a potential treatment option.
    Portaro S; Biasini F; Bramanti P; Naro A; Calabrò RS
    Medicine (Baltimore); 2020 Jul; 99(28):e21117. PubMed ID: 32664137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita.
    Lo Monaco M; D'Amico A; Luigetti M; Desaphy JF; Modoni A
    Clin Neurophysiol; 2015 Feb; 126(2):399-403. PubMed ID: 25065301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal and abnormally persistent paralysis associated with congenital paramyotonia.
    Magot A; David A; Sternberg D; Péréon Y
    BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24939454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inflammatory demyelinating polyneuropathy with pulmonary nocardiosis: A case report.
    Yan C; Liu TT; Gao LT
    Medicine (Baltimore); 2024 Jun; 103(24):e38544. PubMed ID: 38875438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myotonia congenita--a cause of muscle weakness and stiffness.
    Chrestian N; Puymirat J; Bouchard JP; Dupré N
    Nat Clin Pract Neurol; 2006 Jul; 2(7):393-9; quiz following 399. PubMed ID: 16932590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Mexiletine on Muscle Stiffness in Patients With Nondystrophic Myotonia Evaluated Using Aggregated N-of-1 Trials.
    Stunnenberg BC; Raaphorst J; Groenewoud HM; Statland JM; Griggs RC; Woertman W; Stegeman DF; Timmermans J; Trivedi J; Matthews E; Saris CGJ; Schouwenberg BJ; Drost G; van Engelen BGM; van der Wilt GJ
    JAMA; 2018 Dec; 320(22):2344-2353. PubMed ID: 30535218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs.
    Desaphy JF; Carbonara R; Costanza T; Conte Camerino D
    Exp Neurol; 2014 May; 255(100):96-102. PubMed ID: 24613829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Atypical Phenotype of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated with Ocular Palsy, IgM-anti Ganglioside Antibody, and Fever-induced Recurrence.
    Horiuchi M; Hongo Y; Yamazaki K; Komuta Y; Kadoya M; Takazaki H; Furuya Y; Matsui T; Sakamoto N; Ikewaki K; Suzuki K; Kaida K
    Intern Med; 2022 Apr; 61(8):1247-1252. PubMed ID: 34615817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular excitability changes produced by sustained voluntary contraction and response to mexiletine in myotonia congenita.
    Ginanneschi F; Mignarri A; Lucchiari S; Ulzi G; Comi GP; Rossi A; Dotti MT
    Neurophysiol Clin; 2017 Jun; 47(3):247-252. PubMed ID: 28153715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational approach to address therapy in myotonia permanens due to a new SCN4A mutation.
    Desaphy JF; Carbonara R; D'Amico A; Modoni A; Roussel J; Imbrici P; Pagliarani S; Lucchiari S; Lo Monaco M; Conte Camerino D
    Neurology; 2016 May; 86(22):2100-8. PubMed ID: 27164696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inflammatory demyelinating polyneuropathy and psoriasis comorbidity with significantly alleviated in symptoms after secukinumab: case report.
    Jin Y; Chu H; Dong H; Wang H; Wang Q; Zhao X; Qin D; Lu Z; Weng C
    BMC Neurol; 2022 Nov; 22(1):400. PubMed ID: 36324078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myotonia with muscular weakness corrected by exercise. The therapeutic effect of mexiletine].
    Pouget J; Serratrice G
    Rev Neurol (Paris); 1983; 139(11):665-72. PubMed ID: 6677978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.
    Trivedi JR; Bundy B; Statland J; Salajegheh M; Rayan DR; Venance SL; Wang Y; Fialho D; Matthews E; Cleland J; Gorham N; Herbelin L; Cannon S; Amato A; Griggs RC; Hanna MG; Barohn RJ;
    Brain; 2013 Jul; 136(Pt 7):2189-200. PubMed ID: 23771340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flecainide-Responsive Myotonia Permanens With SNEL Onset: A New Case and Literature Review.
    Portaro S; Rodolico C; Sinicropi S; Musumeci O; Valenzise M; Toscano A
    Pediatrics; 2016 Apr; 137(4):. PubMed ID: 26944947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic inflammatory demyelinating polyneuropathy and sarcoidosis: fortuitous association?].
    Ducray F; Costedoat-Chalumeau N; Bouhour F; Rousset H; Vial C
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S85-9. PubMed ID: 18087235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated Acute Exacerbations of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Accompanied by Pain and Swelling in Distal Extremities.
    Murakami T; Kishi M; Tokuda N; Honda M; Hanajima R
    Intern Med; 2024 Mar; 63(5):733-737. PubMed ID: 37468246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study.
    Vicart S; Franques J; Bouhour F; Magot A; Péréon Y; Sacconi S; Nadaj-Pakleza A; Behin A; Zahr N; Hézode M; Fournier E; Payan C; Lacomblez L; Fontaine B
    Neuromuscul Disord; 2021 Nov; 31(11):1124-1135. PubMed ID: 34702654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse with Dysphagia in a Case of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Teramoto H; Morita A; Hara M; Ninomiya S; Shigihara S; Kusunoki S; Kamei S
    Intern Med; 2015; 54(14):1791-3. PubMed ID: 26179538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletine.
    Ceccarelli M; Rossi B; Siciliano G; Calevro L; Tarantino E
    Acta Paediatr; 1992 May; 81(5):453-5. PubMed ID: 1498517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: a long-term follow-up study.
    van Dijk GW; Notermans NC; Franssen H; Wokke JH
    J Neurol; 1999 Dec; 246(12):1134-9. PubMed ID: 10653304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.